Dendreon's Tale of Woes And Missteps Ends in Bankruptcy - Value...

11/10/14

Dendreon's Tale of Woes And Missteps Ends in Bankruptcy
ValueWalk
Dendreon Corporation (NASDAQ:DNDN) announced on Monday, November 10th that it was filing for Chapter 11 bankruptcy protection following an agreement with senior lenders on a restructuring that could mean a reorganization or a sale of its prostate ...
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters BankruptcyXconomy
Skadden, Weil Alum Nab Roles in Dendreon BankruptcyLaw.com
Dendreon Reaches Agreements on Terms of Financial RestructuringMarketWatch

all 252 news articles »

[more]